Kathleen Marie Powis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Infectious | 36 | 2023 | 2026 | 5.480 |
Why?
|
HIV Infections | 77 | 2024 | 16718 | 3.950 |
Why?
|
Infectious Disease Transmission, Vertical | 26 | 2023 | 1320 | 2.860 |
Why?
|
Botswana | 42 | 2024 | 1040 | 2.360 |
Why?
|
Anti-HIV Agents | 23 | 2023 | 4256 | 2.340 |
Why?
|
Anti-Retroviral Agents | 16 | 2023 | 1715 | 1.410 |
Why?
|
HIV-1 | 21 | 2024 | 6939 | 1.330 |
Why?
|
Zidovudine | 8 | 2023 | 620 | 1.180 |
Why?
|
Pregnancy | 51 | 2023 | 29144 | 1.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 15 | 2020 | 1873 | 1.040 |
Why?
|
HIV Protease Inhibitors | 4 | 2022 | 430 | 0.780 |
Why?
|
Infant Mortality | 5 | 2019 | 754 | 0.770 |
Why?
|
Latent Tuberculosis | 1 | 2023 | 225 | 0.750 |
Why?
|
Infant | 32 | 2023 | 35136 | 0.720 |
Why?
|
HIV | 9 | 2023 | 1604 | 0.660 |
Why?
|
Premature Birth | 8 | 2023 | 1721 | 0.640 |
Why?
|
Circumcision, Male | 5 | 2020 | 150 | 0.620 |
Why?
|
Viral Load | 12 | 2023 | 3299 | 0.600 |
Why?
|
Body Height | 2 | 2021 | 1577 | 0.580 |
Why?
|
RNA, Viral | 7 | 2018 | 2902 | 0.580 |
Why?
|
Fetus | 2 | 2021 | 1880 | 0.570 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2023 | 2232 | 0.540 |
Why?
|
Breast Feeding | 8 | 2023 | 1338 | 0.520 |
Why?
|
Infant, Newborn | 26 | 2023 | 25625 | 0.520 |
Why?
|
Birth Weight | 3 | 2023 | 2069 | 0.480 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2017 | 317 | 0.480 |
Why?
|
Nevirapine | 5 | 2022 | 267 | 0.470 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2019 | 2408 | 0.470 |
Why?
|
Mothers | 5 | 2024 | 2165 | 0.460 |
Why?
|
Maternal-Fetal Exchange | 1 | 2016 | 456 | 0.460 |
Why?
|
Reverse Transcriptase Inhibitors | 5 | 2022 | 615 | 0.430 |
Why?
|
Malnutrition | 1 | 2019 | 625 | 0.430 |
Why?
|
Maternal Exposure | 1 | 2019 | 961 | 0.420 |
Why?
|
Female | 72 | 2024 | 380194 | 0.420 |
Why?
|
Oxazines | 3 | 2022 | 298 | 0.400 |
Why?
|
Child | 24 | 2024 | 77709 | 0.400 |
Why?
|
Heterocyclic Compounds, 3-Ring | 3 | 2022 | 215 | 0.400 |
Why?
|
South Africa | 3 | 2022 | 1731 | 0.390 |
Why?
|
Tuberculosis | 1 | 2023 | 1912 | 0.380 |
Why?
|
Child Development | 4 | 2019 | 2223 | 0.370 |
Why?
|
Communicable Diseases | 1 | 2019 | 880 | 0.370 |
Why?
|
Fetal Growth Retardation | 1 | 2014 | 570 | 0.370 |
Why?
|
Benzoxazines | 3 | 2021 | 301 | 0.370 |
Why?
|
Developmental Disabilities | 2 | 2016 | 1456 | 0.360 |
Why?
|
HIV Seropositivity | 3 | 2022 | 971 | 0.360 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1035 | 0.360 |
Why?
|
Progesterone | 1 | 2014 | 776 | 0.350 |
Why?
|
Pre-Eclampsia | 2 | 2023 | 1200 | 0.350 |
Why?
|
Guideline Adherence | 1 | 2019 | 2266 | 0.340 |
Why?
|
Humans | 88 | 2024 | 744343 | 0.330 |
Why?
|
Insulin Resistance | 1 | 2022 | 3864 | 0.330 |
Why?
|
Population Surveillance | 1 | 2019 | 2616 | 0.320 |
Why?
|
Fetal Development | 1 | 2014 | 767 | 0.320 |
Why?
|
Pyridones | 3 | 2022 | 712 | 0.320 |
Why?
|
Stillbirth | 5 | 2023 | 346 | 0.310 |
Why?
|
Anthropometry | 3 | 2021 | 1350 | 0.300 |
Why?
|
Pneumonia | 1 | 2019 | 2133 | 0.300 |
Why?
|
Postpartum Period | 4 | 2022 | 1086 | 0.280 |
Why?
|
Alkynes | 3 | 2021 | 306 | 0.270 |
Why?
|
Cyclopropanes | 3 | 2021 | 416 | 0.250 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1343 | 0.250 |
Why?
|
Protease Inhibitors | 3 | 2022 | 791 | 0.250 |
Why?
|
Pregnancy Outcome | 4 | 2023 | 2795 | 0.250 |
Why?
|
Prevalence | 10 | 2023 | 15226 | 0.230 |
Why?
|
Trichomonas Infections | 1 | 2022 | 43 | 0.220 |
Why?
|
Piperazines | 3 | 2022 | 2488 | 0.220 |
Why?
|
Trichomonas vaginalis | 1 | 2022 | 76 | 0.210 |
Why?
|
Zambia | 1 | 2022 | 261 | 0.200 |
Why?
|
Ritonavir | 2 | 2022 | 322 | 0.190 |
Why?
|
Zimbabwe | 1 | 2021 | 129 | 0.190 |
Why?
|
Vitamin D | 1 | 2014 | 3223 | 0.190 |
Why?
|
Integrase Inhibitors | 1 | 2020 | 12 | 0.190 |
Why?
|
Syphilis | 1 | 2022 | 227 | 0.180 |
Why?
|
Rotavirus Vaccines | 1 | 2020 | 61 | 0.180 |
Why?
|
Hepatitis B Antibodies | 1 | 2020 | 159 | 0.180 |
Why?
|
Adult | 32 | 2023 | 214055 | 0.180 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2020 | 127 | 0.180 |
Why?
|
Infant Formula | 1 | 2021 | 199 | 0.170 |
Why?
|
Disease Reservoirs | 1 | 2019 | 131 | 0.170 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7181 | 0.170 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2020 | 305 | 0.170 |
Why?
|
Prospective Studies | 13 | 2023 | 53288 | 0.170 |
Why?
|
Hepatitis B Vaccines | 1 | 2020 | 194 | 0.170 |
Why?
|
Vaccines, Conjugate | 1 | 2020 | 333 | 0.170 |
Why?
|
Chlamydia Infections | 1 | 2022 | 365 | 0.170 |
Why?
|
Parturition | 3 | 2023 | 441 | 0.170 |
Why?
|
Rural Population | 5 | 2021 | 2210 | 0.170 |
Why?
|
Paternal Exposure | 1 | 2019 | 89 | 0.170 |
Why?
|
Quarantine | 1 | 2020 | 170 | 0.160 |
Why?
|
Gonorrhea | 1 | 2022 | 335 | 0.160 |
Why?
|
Pregnancy Complications | 2 | 2023 | 2861 | 0.160 |
Why?
|
Marijuana Smoking | 1 | 2021 | 253 | 0.160 |
Why?
|
Hospitalization | 6 | 2021 | 10262 | 0.160 |
Why?
|
Lamivudine | 1 | 2019 | 342 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 489 | 0.150 |
Why?
|
Integrases | 1 | 2020 | 533 | 0.150 |
Why?
|
Pneumococcal Vaccines | 1 | 2020 | 391 | 0.150 |
Why?
|
Hepatitis B virus | 1 | 2020 | 513 | 0.140 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 624 | 0.140 |
Why?
|
CD4 Lymphocyte Count | 4 | 2018 | 2559 | 0.140 |
Why?
|
Africa South of the Sahara | 1 | 2019 | 724 | 0.140 |
Why?
|
Adolescent | 15 | 2023 | 85781 | 0.140 |
Why?
|
Male | 29 | 2023 | 350118 | 0.140 |
Why?
|
Serologic Tests | 1 | 2018 | 374 | 0.130 |
Why?
|
Young Adult | 17 | 2021 | 56430 | 0.130 |
Why?
|
HIV Antibodies | 4 | 2024 | 1322 | 0.130 |
Why?
|
Energy Metabolism | 2 | 2017 | 2899 | 0.130 |
Why?
|
Hepatitis B | 1 | 2020 | 695 | 0.130 |
Why?
|
Child Mortality | 1 | 2016 | 198 | 0.120 |
Why?
|
Hypertension | 4 | 2023 | 8480 | 0.120 |
Why?
|
Diarrhea | 1 | 2020 | 1348 | 0.120 |
Why?
|
Prilocaine | 1 | 2012 | 19 | 0.110 |
Why?
|
Foreskin | 1 | 2012 | 31 | 0.110 |
Why?
|
Child, Preschool | 8 | 2022 | 41006 | 0.110 |
Why?
|
Anemia | 2 | 2013 | 1506 | 0.110 |
Why?
|
Neonatal Screening | 1 | 2017 | 591 | 0.110 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 817 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 639 | 0.110 |
Why?
|
Analysis of Variance | 1 | 2021 | 6365 | 0.100 |
Why?
|
Pregnancy Proteins | 1 | 2013 | 229 | 0.100 |
Why?
|
Case-Control Studies | 3 | 2021 | 21746 | 0.100 |
Why?
|
Placental Insufficiency | 1 | 2012 | 51 | 0.100 |
Why?
|
Feces | 1 | 2017 | 1401 | 0.100 |
Why?
|
Equipment and Supplies | 1 | 2014 | 281 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2022 | 2958 | 0.100 |
Why?
|
Cohort Studies | 8 | 2023 | 40561 | 0.100 |
Why?
|
Diabetes, Gestational | 1 | 2021 | 1184 | 0.100 |
Why?
|
Neutropenia | 2 | 2013 | 895 | 0.090 |
Why?
|
Linear Models | 1 | 2021 | 5952 | 0.090 |
Why?
|
Proviruses | 2 | 2023 | 318 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 552 | 0.090 |
Why?
|
Residence Characteristics | 1 | 2019 | 2050 | 0.090 |
Why?
|
Lidocaine | 1 | 2012 | 544 | 0.090 |
Why?
|
Mass Screening | 3 | 2020 | 5255 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2021 | 3966 | 0.080 |
Why?
|
Seasons | 1 | 2014 | 1493 | 0.080 |
Why?
|
Edema | 1 | 2012 | 789 | 0.080 |
Why?
|
Drug Resistance, Viral | 1 | 2013 | 820 | 0.080 |
Why?
|
United States | 6 | 2023 | 69872 | 0.080 |
Why?
|
Body Size | 1 | 2011 | 461 | 0.080 |
Why?
|
Risk Assessment | 2 | 2019 | 23338 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2019 | 3923 | 0.080 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2013 | 780 | 0.070 |
Why?
|
Cameroon | 2 | 2017 | 71 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 9959 | 0.070 |
Why?
|
Anti-Infective Agents | 1 | 2013 | 972 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3674 | 0.070 |
Why?
|
Escherichia coli | 1 | 2017 | 4217 | 0.060 |
Why?
|
Body Weight | 1 | 2016 | 4669 | 0.060 |
Why?
|
Exercise | 1 | 2021 | 5615 | 0.060 |
Why?
|
Mitochondria | 1 | 2017 | 3520 | 0.060 |
Why?
|
Infant, Small for Gestational Age | 2 | 2020 | 440 | 0.060 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2017 | 251 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2018 | 25043 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2013 | 2564 | 0.060 |
Why?
|
Antibodies, Neutralizing | 2 | 2024 | 1978 | 0.060 |
Why?
|
Risk Factors | 9 | 2023 | 72290 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2017 | 12026 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2023 | 4386 | 0.060 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.050 |
Why?
|
Fertilization | 1 | 2023 | 196 | 0.050 |
Why?
|
Killer Cells, Natural | 2 | 2022 | 2133 | 0.050 |
Why?
|
Weight Gain | 2 | 2022 | 2292 | 0.050 |
Why?
|
Chlamydia trachomatis | 1 | 2022 | 246 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2023 | 336 | 0.050 |
Why?
|
Sex Factors | 1 | 2014 | 10397 | 0.050 |
Why?
|
Insulin | 1 | 2015 | 6580 | 0.050 |
Why?
|
Neisseria gonorrhoeae | 1 | 2022 | 238 | 0.050 |
Why?
|
Viremia | 1 | 2023 | 736 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2013 | 5317 | 0.040 |
Why?
|
Quinolones | 1 | 2022 | 367 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2017 | 77449 | 0.040 |
Why?
|
HIV Integrase Inhibitors | 1 | 2020 | 142 | 0.040 |
Why?
|
Placenta | 2 | 2022 | 1698 | 0.040 |
Why?
|
Incidence | 4 | 2019 | 20947 | 0.040 |
Why?
|
Logistic Models | 1 | 2013 | 13408 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12354 | 0.040 |
Why?
|
HIV Antigens | 1 | 2018 | 347 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2019 | 457 | 0.040 |
Why?
|
Biometry | 1 | 2020 | 558 | 0.040 |
Why?
|
Parity | 1 | 2020 | 929 | 0.040 |
Why?
|
Africa | 1 | 2019 | 673 | 0.040 |
Why?
|
Carnitine | 1 | 2017 | 246 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1836 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1769 | 0.030 |
Why?
|
Middle Aged | 9 | 2020 | 213383 | 0.030 |
Why?
|
Hospitals, District | 1 | 2016 | 106 | 0.030 |
Why?
|
United Nations | 1 | 2016 | 165 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 783 | 0.030 |
Why?
|
Cannabis | 1 | 2021 | 439 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Counseling | 1 | 2022 | 1523 | 0.030 |
Why?
|
Sexual Partners | 1 | 2018 | 730 | 0.030 |
Why?
|
Awareness | 1 | 2018 | 640 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3200 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2020 | 1695 | 0.030 |
Why?
|
Phylogeny | 1 | 2019 | 2803 | 0.030 |
Why?
|
Caregivers | 1 | 2024 | 2094 | 0.030 |
Why?
|
Survival Analysis | 2 | 2017 | 10252 | 0.030 |
Why?
|
Specimen Handling | 1 | 2016 | 694 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1157 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2371 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3778 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1049 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 1000 | 0.020 |
Why?
|
Community Health Services | 1 | 2016 | 650 | 0.020 |
Why?
|
Administration, Topical | 1 | 2012 | 690 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2715 | 0.020 |
Why?
|
Goals | 1 | 2016 | 706 | 0.020 |
Why?
|
Gestational Age | 1 | 2019 | 3493 | 0.020 |
Why?
|
Monocytes | 1 | 2019 | 2596 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 2987 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2013 | 599 | 0.020 |
Why?
|
Perinatal Care | 1 | 2011 | 227 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2013 | 643 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12797 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 2971 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8554 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2018 | 63114 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2021 | 2065 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7785 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40075 | 0.020 |
Why?
|
Medication Adherence | 1 | 2017 | 2063 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12720 | 0.020 |
Why?
|
Inpatients | 1 | 2016 | 2518 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2014 | 1540 | 0.020 |
Why?
|
Genetic Variation | 1 | 2019 | 6544 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13989 | 0.010 |
Why?
|
Cause of Death | 1 | 2013 | 3584 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
Animals | 1 | 2014 | 168757 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4803 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39050 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14722 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3022 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18111 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2684 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12951 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12245 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2011 | 15540 | 0.010 |
Why?
|
Aged | 1 | 2016 | 163280 | 0.000 |
Why?
|